Inventor

CLARK MIKE A

US11 patents

⚠️ This page may combine multiple inventors who share the name “CLARK MIKE A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PHOENIX PHARMACOLOGICS INC

3 patents

US6913915B2Jul 5, 2005

PEG-modified uricase

PHOENIX PHARMACOLOGICS INC105 citations93

US6737259B1May 18, 2004

Modified arginine deiminase

PHOENIX PHARMACOLOGICS INC30 citations91

US6645739B2Nov 11, 2003

Yeast expression systems, methods of producing polypeptides in yeast, and compositions relating to same

PHOENIX PHARMACOLOGICS INC33 citations91

POLARIS GROUP

2 patents

US7323167B2Jan 29, 2008

Method of treatment with modified arginine deiminase

POLARIS GROUP15 citations91

US7785579B2Aug 31, 2010

Modified tumor necrosis factor

POLARIS GROUP0 citations51

ENZON INC

2 patents

US5728560AMar 17, 1998

Method of treating CD4+ T cell lymphopenia in immuno-compromised patients

ENZON INC24 citations88

US5527775AJun 18, 1996

Reduction of mammalian neoplasms with phospholipase A2 activating substances

ENZON INC12 citations73

PHOENIX PHARAMACOLOGICS INC

1 patent

US6183738B1Feb 6, 2001

Modified arginine deiminase

PHOENIX PHARAMACOLOGICS INC204 citations96

PHOENIX PHARMACOLOGIES INC

1 patent

US6635462B1Oct 21, 2003

Mutated form of arginine deiminase

PHOENIX PHARMACOLOGIES INC34 citations86

(unassigned)

1 patent

US5786154AJul 28, 1998

Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis

8 citations71

BOMALASKI JOHN S

1 patent

US5367063ANov 22, 1994

Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis

BOMALASKI JOHN S3 citations60